“`html
The SPDR S&P Biotech ETF (XBI) experienced a significant inflow of approximately $480.2 million, marking a 7.7% week-over-week increase in outstanding units, which rose from 57,675,000 to 62,125,000. This change was reported today, highlighting strong investor interest in the biotech sector.
XBI’s 52-week price range spans from a low of $66.66 to a high of $110.96, with the last trade recorded at $107.90. The ETF’s performance is being closely monitored against its 200-day moving average as it shows notable market activity.
“`
